Post-marketing Surveillance (PMS) to Observe the Safety and Effectiveness of Lyrica CR Extended Release Tablets
NCT04171453
·
clinicaltrials.gov ↗
UNKNOWN
Status
600
Enrollment
INDUSTRY
Sponsor class
Conditions
Peripheral Neuropathic Pain
Interventions
DRUG:
Lyrica CR (Pregabalin)
Sponsor
Viatris Korea